Merck (MRK) Accumulated Expenses (2009 - 2011)

Merck (MRK) has 3 years of Accumulated Expenses data on file, last reported at $8.6 billion in Q1 2011.

• Quarterly Accumulated Expenses rose 1.37% year-over-year to $8.6 billion in Q1 2011, while the trailing twelve-month figure through Mar 2011 was $8.6 billion (up 1.37% YoY) and the FY2010 annual result came in at $8.5 billion, down 9.95% from the prior year.
• Accumulated Expenses was little changed at $8.6 billion in Q1 2011 per MRK's latest filing, from $8.5 billion in the prior quarter.
• Across five years, Accumulated Expenses topped out at $9.5 billion in Q4 2009 and bottomed at $828.0 million in Q2 2009.
• The 3-year median for Accumulated Expenses is $8.3 billion (2010), against an average of $6.5 billion.
• Peak annual rise in Accumulated Expenses reached 743.8% in 2010, while the deepest fall reached 9.95% in 2010.
• Tracing MRK's Accumulated Expenses over 3 years: stood at $9.5 billion in 2009, then slipped by 9.95% to $8.5 billion in 2010, then rose by 0.48% to $8.6 billion in 2011.
• Per Business Quant, the three latest MRK Accumulated Expenses figures stand at $8.6 billion (Q1 2011), $8.5 billion (Q4 2010), and $8.2 billion (Q3 2010).

Peer Comparison